A case of acute ventricular capture threshold rise associated with flecainide acetate

Tae Soo Kang, Young Won Yoon, Sungha Park, Bum Kee Hong, Dongsoo Kim, Hyuck Moon Kwon, Hyun Seung Kim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Antiarrhythmic agents may increase capture threshold, but this is rarely of clinical significance. Flecainide acetate, a class IC agent, is reported to have a significant effect on the myocardial capture threshold. In this presentation, we report the case of a 72-year-old male, with a previously implanted VVI pacemaker due to sick sinus syndrome, who was treated with flecainide acetate for paroxysmal atrial arrhythmia control. During the fifteenth day of treatment, an abrupt rise in the ventricular capture threshold with ventricular pacing failure was noted. The capture threshold decreased two days after discontinuation of flecainide acetate.

Original languageEnglish
Pages (from-to)152-154
Number of pages3
JournalYonsei medical journal
Volume47
Issue number1
DOIs
Publication statusPublished - 2006 Feb 6

Fingerprint

Flecainide
Sick Sinus Syndrome
Cardiac Arrhythmias

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Kang, Tae Soo ; Yoon, Young Won ; Park, Sungha ; Hong, Bum Kee ; Kim, Dongsoo ; Kwon, Hyuck Moon ; Kim, Hyun Seung. / A case of acute ventricular capture threshold rise associated with flecainide acetate. In: Yonsei medical journal. 2006 ; Vol. 47, No. 1. pp. 152-154.
@article{56b27f8064574941a190b3ef5daaec4e,
title = "A case of acute ventricular capture threshold rise associated with flecainide acetate",
abstract = "Antiarrhythmic agents may increase capture threshold, but this is rarely of clinical significance. Flecainide acetate, a class IC agent, is reported to have a significant effect on the myocardial capture threshold. In this presentation, we report the case of a 72-year-old male, with a previously implanted VVI pacemaker due to sick sinus syndrome, who was treated with flecainide acetate for paroxysmal atrial arrhythmia control. During the fifteenth day of treatment, an abrupt rise in the ventricular capture threshold with ventricular pacing failure was noted. The capture threshold decreased two days after discontinuation of flecainide acetate.",
author = "Kang, {Tae Soo} and Yoon, {Young Won} and Sungha Park and Hong, {Bum Kee} and Dongsoo Kim and Kwon, {Hyuck Moon} and Kim, {Hyun Seung}",
year = "2006",
month = "2",
day = "6",
doi = "10.3349/ymj.2006.47.1.152",
language = "English",
volume = "47",
pages = "152--154",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "1",

}

A case of acute ventricular capture threshold rise associated with flecainide acetate. / Kang, Tae Soo; Yoon, Young Won; Park, Sungha; Hong, Bum Kee; Kim, Dongsoo; Kwon, Hyuck Moon; Kim, Hyun Seung.

In: Yonsei medical journal, Vol. 47, No. 1, 06.02.2006, p. 152-154.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A case of acute ventricular capture threshold rise associated with flecainide acetate

AU - Kang, Tae Soo

AU - Yoon, Young Won

AU - Park, Sungha

AU - Hong, Bum Kee

AU - Kim, Dongsoo

AU - Kwon, Hyuck Moon

AU - Kim, Hyun Seung

PY - 2006/2/6

Y1 - 2006/2/6

N2 - Antiarrhythmic agents may increase capture threshold, but this is rarely of clinical significance. Flecainide acetate, a class IC agent, is reported to have a significant effect on the myocardial capture threshold. In this presentation, we report the case of a 72-year-old male, with a previously implanted VVI pacemaker due to sick sinus syndrome, who was treated with flecainide acetate for paroxysmal atrial arrhythmia control. During the fifteenth day of treatment, an abrupt rise in the ventricular capture threshold with ventricular pacing failure was noted. The capture threshold decreased two days after discontinuation of flecainide acetate.

AB - Antiarrhythmic agents may increase capture threshold, but this is rarely of clinical significance. Flecainide acetate, a class IC agent, is reported to have a significant effect on the myocardial capture threshold. In this presentation, we report the case of a 72-year-old male, with a previously implanted VVI pacemaker due to sick sinus syndrome, who was treated with flecainide acetate for paroxysmal atrial arrhythmia control. During the fifteenth day of treatment, an abrupt rise in the ventricular capture threshold with ventricular pacing failure was noted. The capture threshold decreased two days after discontinuation of flecainide acetate.

UR - http://www.scopus.com/inward/record.url?scp=33745050014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745050014&partnerID=8YFLogxK

U2 - 10.3349/ymj.2006.47.1.152

DO - 10.3349/ymj.2006.47.1.152

M3 - Article

C2 - 16502500

AN - SCOPUS:33745050014

VL - 47

SP - 152

EP - 154

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 1

ER -